0001562180-17-003381.txt : 20171030
0001562180-17-003381.hdr.sgml : 20171030
20171030165717
ACCESSION NUMBER: 0001562180-17-003381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171026
FILED AS OF DATE: 20171030
DATE AS OF CHANGE: 20171030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gavin Robert M.
CENTRAL INDEX KEY: 0001608023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 171163030
MAIL ADDRESS:
STREET 1: C/O PROTEINSIMPLE
STREET 2: 3040 OAKMEAD VILLAGE DRIVE
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-10-26
false
0000842023
BIO-TECHNE Corp
TECH
0001608023
Gavin Robert M.
C/O BIO-TECHNE CORPORATION
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
false
true
false
false
Sen. VP Protein Platforms
Common Stock
1667.00
D
Restricted Stock Units
2017-10-26
4
A
false
1949.00
0.00
A
Common Stock
1949.00
1949.00
D
Stock Options (Right to buy)
125.05
2017-10-26
4
A
false
10742.00
0.00
A
2024-08-09
Common Stock
10742.00
10742.00
D
Stock Options (Right to buy)
125.05
2017-10-26
4
A
false
14323.00
0.00
A
2024-08-09
Common Stock
14323.00
14323.00
D
Restricted Stock Units
Common Stock
1500.00
1500.00
D
Restricted Stock Units
Common Stock
2111.00
2111.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
12500.00
12500.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
9375.00
9375.00
D
Stock Option (Right to Buy)
93.32
2021-07-31
Common Stock
10000.00
10000.00
D
Stock Option (Right to Buy)
90.25
2021-11-30
Common Stock
5000.00
5000.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
13028.00
13028.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
17371.00
17371.00
D
Stock Options (Right to buy)
93.32
2021-07-31
Common Stock
16667.00
16667.00
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Vests 3,580 shares on 8/9/2018 and 3,581 shares each on 8/9/2019, 8/9/2020, 8/9/2021.
Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock.
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
Vests 4,343 shares on each 8/18/2017, 8/18/2018 and 8/18/2019 and 4,342 shares on 8/18/2020
Fully exercisable
Due to an administrative error, the Form 4 filed by Reporting Person on February 3, 2017 contained a duplicate of the Table II grants reported in the August 22, 2016 Form 4 filing.
/s/ Brenda S. Furlow, attorney in fact for Robert M. Gavin pursuant to Power of Attorney filed here with
2017-10-30
EX-24
2
gavinpoa2017.txt
GAVINPOA2017
POWER OF ATTORNEY
The undersigned hereby constitutes and
appoints Brenda S. Furlow, James Hippel, Anna
Weispfenning, Melodie R. Rose, Andrew Nick,
Sarah Tucher or either of them acting alone,
the undersigned's true and lawful attorneys-
in-fact and agent with full power of
substitution and resubstitution, for the
undersigned and in the undersigned's name,
place and stead, in any and all capacities,
to sign any or all Forms 3, Forms 4 and
Forms 5 relating to beneficial ownership of
securities of Bio-Techne Corporation (the
"Issuer"), to file the same, with all
exhibits thereto and other documents in
connection therewith, with the Securities and
Exchange Commission and to deliver a copy of
the same to the Issuer, granting unto said
attorney-in-fact and agent full power and
authority to do and perform each and every
act and thing requisite and necessary to be
done in and about the premises, as fully to
all intents and purposes as the undersigned
might or could do in person, hereby ratifying
and confirming all said attorneys-in-fact and
agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue
thereof. The undersigned acknowledges that
the foregoing attorney-in-fact, in serving in
such capacity at the request of the
undersigned, is not assuming any of the
undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of
1934.
This Power of Attorney shall remain in
effect until such time as the undersigned is
no longer subject to the provisions of
Section 16 of the Securities Exchange Act of
1934 with respect to securities of the
Issuer.
IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be executed
as of this 5th day of October, 2017.
/s/ Robert Gavin